BioCentury
ARTICLE | Company News

Epigenomics' Epi proColon gets Priority Review

February 22, 2013 2:05 AM UTC

Epigenomics AG (Xetra:ECX) said FDA accepted and granted Priority Review to a PMA for its Epi proColon 2.0 test to detect colorectal cancer. Epigenomics said it expects a decision from FDA next half. ...